Human Metabolome Technologies (6090) Earnings: Operating Income Decreased by 15.9% YoY to 209 Million Yen

Human Metabolome Technologies (6090) has released its financial results, reporting that operating income decreased by 15.9% year-on-year to 209 million yen. Net sales were 1,421 million yen (a 2.3% decrease year-on-year), ordinary income was 206 million yen (a 14.2% decrease), and net income attributable to owners of the parent was 200 million yen (a 21.9% decrease). Despite the contraction in revenue and profit, the operating profit margin remained solid at 14.8%.

From a financial and balance sheet perspective, operating cash flow stood at a positive 208 million yen, and after accounting for investing cash flow (-83 million yen), free cash flow (operating plus investing cash flow) for FY2026/6 was positive at 125.210 million yen. The equity ratio stands at an exceptionally high 80.2%, reflecting a very robust financial foundation. Furthermore, the company reported a Return on Equity (ROE) of 10.85% and a Return on Assets (ROA) of 8.79%, alongside an EBITDA of 320 million yen, reflecting a resilient underlying financial structure.

---

Correction (September 29, 2026): Corrected the specified amounts, rates or reporting periods against the original company disclosure; the verified changes are recorded in the correction ledger. Source